JPRN-UMIN000012937招募中未知
Efficacy and safety of Simeprevir/PEG alpha-IFN-2a/RBV therapy for patients with chronic hepatitis C after resection of hepatocellular carcinoma - Simeprevir/PEG alpha-IFN-2a/RBV therapy for patients with chronic hepatitisC after resection of HCC
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Concomitant herbal medication of Sho-saiko-to. 2.History of interstitial pneumonia 3.Autoimmune hepatitis 4.Allegic to vaccine or biological preperations. 5.Uncontrolled cardiopathy. 6.Hemoglobinopathy. 7.Chronic renal failure or renal dysfunction with creatinine clearance <=50mL/min. 8.Severe depression or psychosomatic disorders. 9.Patients with moderate liver diseases.(Child-Pugh grade BorC) 10.Patient with a history of photosensitivity 11.Women of childbearing potential and pregnancy, lactating women. 12.Drug allegy against interferon or nucleoside analog. 13.Patients receiving rifampicin, rifabutin, phenytoin, carbamazepine, phenobarbital, systemic administration of dexamethasone, azole antifungal drug, clarithromycin, erythromycin, diltiazem, verapamil hydrochloride, cobicistat included drugs,HIV Protease inhibitor, modafinil, nonnucleoside reverse transcriptase inhibitor(except for rilpivirine hydrochloride), bosentan hydrate, St John's Wort included foods, cyclosporine, flecainide, propafenone. 14.Other conditions considered inappropriate by attending physician
研究者
相似试验
已完成
不适用
Efficacy and safety of simeprevir/pegylated-interferon/ribavirin combination therapy with Vitamin D3 in chronic hepatitis C patients: multi-center, open label, randomized, controlled studyChronic hepatitis CJPRN-UMIN000013017ippon Medical School Chiba Hokusoh Hospital150
已完成
不适用
Efficacy and safety of simeprevir plus pegylated intereferon combination therapy for HCV genotype 1 patients with chronic renal failurechronic infection with hepatitis C virusJPRN-UMIN000012668Osaka University Graduate school of Medicine45
尚未招募
不适用
Efficacy and safety of simeprevir with pegylated interferon alfa and low dose of ribavirin for patients with chronic hepatitis C genotype 1 and low hemoglobin levelJPRN-UMIN000018476Osaka University Graduate School of Medicine, Department of Gastroenterology and Hepatology55
尚未招募
不适用
Efficacy and safety of simeprevir with pegylated interferon alfa and ribavirin in patients with chronic hepatitis CPatients with chronic hepatitis C virus infectionJPRN-UMIN000012183Osaka University Graduate School of Medicine, Department of Gastroenterology and Hepatology500
已完成
不适用
Efficacy and safety of simeprevir with pegylated interferon alfa-2b and ribavirin in kidney transplant patients with chronic hepatitis CPatients with chronic hepatitis C virus infectionJPRN-UMIN000013088Osaka University18